CareFusion Corp.’s medical pumps, ventilators and medicine dispensers have already attracted the attention of investors who sent the company’s stock to a record last week. Now, it could get a look from private-equity firms.
Baxter International Inc., the world’s second-largest maker of dialysis products, agreed to buy Swedish competitor Gambro AB for 18.3 billion kronor ($2.8 billion) to expand its kidney-equipment business.
Kinetic Concepts Inc. is enticing private equity firms with the U.S. medical products industry’s cheapest valuation for what would be the biggest leveraged buyout since the collapse of Lehman Brothers Holdings Inc.
Kirkland & Ellis LLP advised Baxter International Inc., the world’s second-largest maker of dialysis products, on an agreement to buy Swedish competitor Gambro AB for 18.3 billion kronor ($2.8 billion) to expand its kidney- equipment business.
Johnson & Johnson, the world’s second-biggest seller of health-care products, said third- quarter profit slipped 6.4 percent as the company spent more to promote new drugs and lost sales to generic competition.
Johnson & Johnson, the world’s second-biggest maker of health-care products, raised its full- year earnings forecast after quarterly profit climbed on the divestiture of an older drug and revenue from new medicines.
Johnson & Johnson’s newfound dominance of the orthopedic-device market, cemented by its $21.3 billion acquisition of Synthes Inc. , may drive rivals Zimmer Holdings Inc. and Stryker Corp. to seek purchases of their own.